Related Experiment Videos
Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease
P J van Genderen1, J J Michiels, J J Bakker
1Department of Haematology, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Vox Sanguinis
|January 1, 1994
Abstract:
An 82-year-old patient with acquired von Willebrand's disease in association with a non-Hodgkin's lymphoma and a benign IgG-lambda monoclonal paraproteinemia is described with severe recurring nasopharyngeal bleedings, who responded poorly to desmopressin (DDAVP) and factor VIII/von Willebrand factor concentrates but was successfully treated with high-dose e intravenous gamma-globulin therapy.